Roche to Develop Companion Diagnostic Test for Dalcetrapi
Roche, a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, has signed an agreement to develop a […]
Tags: Business/Finance, Cardiovascular disease, CEO, CHF, CHUGAI PHARMACEUTICAL CO. LTD., clinical trial, DalCor Pharmaceuticals, FDA, GENENTECH INC., Head, Health/Medical/Pharmaceuticals, Hoffmann-La Roche, Japan, leader, M&A, majority shareholder, Paul Brown, personalized healthcare, Pharmaceutical industry in the People's Republic of China, Pharmaceutical sciences, pharmaceuticals, Pharmacology, research, research-focused healthcare, Robert McNeil, Roche, Roche Diagnostics, Roche Holding Ltd, Roche Molecular Diagnostics, science, United States
New test for Hepatitis B
The new hepatitis B surface antigen (HBsAg) quant test enables physicians to assess a patient
Personalised, Connected Health Market by Continua Health Alliance
Continua Health Alliance announced the availability of three new Continua Certified devices from member companies.
